169324 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids Intracellular protein regulatory factors and their receptors, e.g. including ion channels
METHODS AND COMPOSITIONS FOR MODULATING CALCIUM CHANNELS
#1502Non-functional P2Xreceptor
#1503Compositions and method of treating hypoxia-associated diseases
#1504Transcriptional repression of sodium-iodide symporter in thyroid carcinoma
#1505Methods, products and treatments for diabetes
#1506METHOD FOR THE DETERMINATION OF THE ACTIVITY OF THE ORGANIC CATION TRANSPORTER
#1507Insecticidal compounds and methods for selection thereof
#1508Cell-based fluorescent assays for identifying alpha and delta ENaC modulators
#1509ZINC BINDING COMPOUNDS AND THEIR METHOD OF USE
#1510VDCC Gamma-8 Ion Channel
#1511Determination of sFlt-1:angiogenic factor complex
#1512METHODS FOR IDENTIFYING COMPOUNDS THAT MODULATE PHB DOMAIN PROTEIN ACTIVITY AND COMPOSITIONS THEREOF
#1513Kcnn3 as diagnostic and therapeutic target for neurodegenerative diseases
#1514Screening compounds for activity in modulating chloride ion transport
#1515Methods to identify inhibitors of Runx1-mediated expression of nociceptive receptors and ion channels
#1516Canine transient receptor potential V2 (cTRPV2) and methods of screening for TRPV2 channel modulators
#1517METHODS AND COMPOSITIONS RELATING TO EXPRESSION FACTORS
#1518Methods and devices for diagnosis of appendicitis
#1519Methods for tissue analysis
#1520Method for identifying ester coolers
#1521METHODS OF IDENTIFYING COMPOUNDS THAT DECREASE INTRAOCULAR PRESSURE
#1522Kir channel modulators
#1523Methods and compositions for cancer treatment relating to BRCA1 BRCT domain recognition of phosphorylated BACH1
#1524METHOD FOR TREATING CENTRAL PAIN SYNDROM OR FOR INDUCING CENTRALLY GENERATED PAIN IN AN ANIMAL MODEL
#1525SCREENING ASSAY TO IDENTIFY MODULATORS OF THE SLEEP/WAKE CYCLE
#1526NOVEL NON-SELECTIVE CATION CHANNEL IN NEURONAL CELLS AND METHOD FOR TREATING BRAIN SWELLING
#1527Method for determining ion channel modulating properties of a test reagent
#1528Non-desensitizing mutant of the transient receptor potential TRPM5 ion channel
#1529Diagnostic and Therapeutic Target SLC39A11 Proteins for Neurodegenerative Diseases
#1530METHOD FOR THE PREVENTION AND TREATMENT OF ESSENTIAL TREMOR BY REGULATING ALPHA1G T-TYPE CALCIUM CHANNEL OR BY T-TYPE CALCIUM CHANNEL BLOCKERS
#1531NOGO RECEPTOR FUNCTIONAL MOTIFS AND PEPTIDE MIMETICS RELATED THERETO AND METHODS OF USING THE SAME
#1532USE OF HISTOGRANIN AND HISTOGRANIN-LIKE COMPOUNDS AS INHIBITORS OF P2X7 RECEPTOR FUNCTION AND AS ANTI-ARTHRITIC AGENTS
#1533Electrophysiological assays using oocytes that express human enac and the use of phenamil to improve the effect of enac enhancers in assays using membrane potential reporting dyes
#1534Cellular upregulation of VEGF receptor expression using nanofibrillar articles
#1535Software integrated cytometric assay for quantification of the human polymorphonuclear leukocyte FcγRI receptor (CD64)
#1536Identification of TRPML3 (MCOLN3) as a Salty Taste Receptor and Use in Assays for Identifying Taste (Salty) Modulators and/or Therapeutics that Modulate Sodium Transport, Absorption or Excretion and/or Aldosterone and/or Vasopressin Production or Release
#1537Prodrugs of modulators of ABC transporters
#1538VASCULAR ENDOTHELIAL GROWTH FACTOR C (VEGF-C) PROTEIN AND GENE, MUTANTS THEREOF, AND USES THEREOF
#1539Screening test drugs to identify their effects on cell membrane voltage-gated ion channel
#1540Human T1R2 polypeptide functional assays
#1541Methods of screening for LTRPC7 modulators
#1542Methods and compositions relating to promoter regulation by MUC1 and KLF proteins
#1543MONOCARBOXYLATE TRANSPORTERS EXPRESSED IN CANCER CELLS
#1544Sour/Acid Taste Receptors Assays, Genes and Proteins
#1545Methods of treating neurological conditions with hematopoeitic growth factors
#1546METHODS FOR PROMOTING DOPAMINERGIC NEURONAL DEVELOPMENT BY USING NG4A-SUBFAMILY AND WNT-LIGANDS
#1547ATM-dependent phosphorylation of Sp1 is involved in the cellular response to DNA damage and enhances cellular survival after DNA damage
#1548METHODS OF THERAPY AND DIAGNOSIS USING TARGETING OF CELLS THAT EXPRESS KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR-LIKE PROTEINS
#1549Cardiovascular and Brain Cell Therapy Using Intracellular Ryanodine Receptor Modulation by the Estrogen Receptor Beta
#1550Voltage sensor domains of voltage-dependent ion channel proteins and uses thereof
#1551Method for screening an enhancer or a masker of salty taste
#1552METHODS AND COMPOSITIONS FOR MODULATING HEPATOCYTE GROWTH FACTOR ACTIVATION
#1553PEPTIDE-BASED REGULATION OF GAP JUNCTIONS
#1554Human FGF-21 gene and gene expression products
#1555REGULATOR OF BASAL CELLULAR CALCIUM CONCENTRATION AND METHODS OF USE
#1556Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
#1557Quantum dot labeled stem cells for use in providing pacemaker function
#1558NUCLEOTIDE SEQUENCE ENCODING A MODULATOR OF NF-KB
#1559Channel Current Cheminformatics And Bioengineering Methods For Immunological Screening, Single-Molecule Analysis, And Single-Molecular-Interaction Analysis
#1560Polypeptides and use thereof
#1561Functional identification of proteins underlying Icrac activity in a cell
#1562VOLTAGE-GATED ION CHANNEL MUTANTS FOR USE IN IDENTIFYING ION CHANNEL MODULATING COMPOUNDS
#1563ACACS As Modifiers of the IGF Pathway and Methods of Use
#1564Membrane receptor for retinol binding protein mediates cellular uptake of vitamin A, methods of use and compositions
#1565Inhibitors of BCL-2
#1566Human T1R2 nucleic acid sequences and polypeptides
#1567ERG-1 Peptides and Polynucleotides and Their Use in the Treatment and Diagnosis of Disease
#1568Nell-1 enhanced bone mineralization
#1569Method for Improving Symptom of Mood Disorder
#1570Platelet biomarkers for cancer
#1571Constitutively open hERG (Kv11.1) mutant channels
#1572METHOD AND SYSTEM FOR DETECTING PHARMACOLOGICALLY ACTIVE SUBSTANCES BY MEASURING MEMBRANE CURRENTS WITH EXTRACELLULAR SENSORS
#1573METHODS OF IDENTIFYING MODULATORS OF HYPERPOLARIZATION-ACTIVATED CYCLIC NUCLEOTIDE-GATED (HCN) CHANNELS
#1574Assays and methods for determining STIM2 activity
#1575ALDOs as modifiers of the IGF pathway and methods of use
#1576Methods for identifying modulators of ion channels
#1577Soluble ErbB3 method of detection
#1578Association Between the Tdoa Gene and Osteoarthritis
#1579METHODS AND COMPOSITIONS FOR AFFECTING CYCLOPHILIN A REGULATION OF KINASES IN MODULATING CELLULAR ACTIVITIES
#1580METHOD AND KIT FOR DETERMINING THE AMOUNT OF DNA BINDING PROTEIN
#1581Orphan Receptor Tyrosine Kinase as a Target in Breast Cancer
#1582Method by Using Human or Mice-Isg12 to Develop and Prepare Drugs and Single Nucleotide Polymorphism in the Isg12 Gene for Diagnostic Use
#1583System for screening eukaryotic membrane proteins
#1584Deregulated Genes and/or Processes in Inflammatory Arthritis
#1585Autocrine growth factor receptor antibodies and methods
#1586Mechanosensitive ion channels and methods of use
#1587AMPLIFICATION OF HUMAN MDM2 GENE IN HUMAN TUMORS
#1588T-bet compositions and methods of use thereof
#1589Mutated HOXB4 proteins with improved stability, and methods of use thereof
#1590SHC protein-related methods and compositions
#1591Cultured muscle cells with high metabolic activity and method for production of the cultured muscle cells
#1592Compunds and compositions that cause non-apoptotic cell death and uses thereof
#1593Nanoscale Neuromodulating Platform For Retina Neuron Activation Apparatus and Method
#1594Calcium channel proteins and uses thereof
#1595Method for Screening Substance by Measuring PPAR DELTA Activating Effect and Agent
#1596Methods of identifying modulators of L-glutamate-gated chloride channel proteins from
#1597Methods of culturing dermal papilla cells
#1598Membrane-Anchoring Fluorescent Probe
#1599Selective and dual-action p53/MDM2/MDM4 antagonists
#1600Compositions and methods for gene expression
#1601High throughput screen utilizing newly discovered intramolecular neuronal calcium channel interactions to discover new analgesics
#1602METHODS OF TREATING NEUROLOGICAL CONDITIONS WITH HEMATOPOEITIC GROWTH FACTORS
#1603Method of detecting early immune activation
#1604Soluble ErbB3 receptor isoforms
#1605Methods and Compositions Involving A1c Subunit of L-Type Calcium Channels in Smooth Muscle Cells
#1606ASSAY SYSTEMS AND METHODS FOR DETECTING MOLECULES THAT INTERACT WITH SK2 CHANNELS
#1607Soluble ErbB3 and treatment of cancer
#1608Methods for inhibiting heregulin and treating cancer
#1609METHOD OF IMMOBILIZING MEMBRANE-ASSOCIATED MOLECULES
#1610Soluble ErbB3 receptor isoforms
#1611FGF21 upregulates expression of GLUT-1 in a βklotho-dependent manner
#1612Polynucleotides encoding acetylcholine-gated chloride channel subunits of
#1613Use of precursors of tachykinins and/or their fragments in medical diagnostic
#1614PPAR active compounds
#1615Compositions and methods for modulating calcium flux, glucose homeostasis and apoptosis
#1616Compounds and methods to enhance rAAV transduction
#1617Increasing life span by modulation of Smek
#1618Modulation of PPARgamma2 gene promoter by FOXO1
#1619Method for Using Division Arrested Cells in Screening Assays
#1620THERAPEUTIC AGENT FOR CANCER, INFLAMMATION, AND AUTO-IMMUNE DISEASE CONTAINING INHIBITOR OF ZINC FINGER PROTEIN 91
#1621METHODS AND COMPOSITIONS FOR AFFECTING SUBSTRATE DOCKING OF KINASES IN MODULATING CELLULAR ACTIVITIES
#1622T1R HETERO-OLIGOMERIC TASTE RECEPTORS AND CELL LINES THAT EXPRESS SAID RECEPTORS AND USE THEREOF FOR IDENTIFICATION OF TASTE COMPOUNDS
#1623System for seizure suppression
#1624Netrin receptors
#1625VEGF-C ΔRΔRmutants and uses thereof
#1626Vascular endothelial growth factor C (VEGF-C) protein diagnostic
#1627Methods of treating neurological conditions with hematopoeitic growth factors
#1628Compositions and methods for increasing bone mineralization
#1629Methods For Identifying Compounds Capable of Modulating the Hydrolase Activity of Clca Protein
#1630Method for identifying the agonistic activity of a target compound on a potassium channel
#1631Apparatus for detecting and recording cellular responses
#1632Trp/his exchange and kynurenine induced Trp transport
#1633Signalling Assay and Cell Line
#1634COMPOSITIONS AND METHODS FOR MODULATING C-REL-DEPENDENT CYTOKINE PRODUCTION
#1635Use of Trpc Channel for the Treatment of a Cardiovascular Disease
#1636T1R2 binding assays
#1637Human T1R2 taste receptor polypeptides
#1638Methods and Systems for Treating Asthma and Other Respiratory Diseases
#1639METHODS FOR MODULATING A DRUG-RELATED EFFECT OR BEHAVIOR
#1640Process for identification of compounds for modulating the activity of sodium/calcium exchange transporter
#1641Compounds and methods for pharmico-gene therapy of epithelial sodium channel associated disorders
#1642Astrocyte Elevated Gene-1 And Its Promoter In Treatments For Neurotoxicity And Malignancy
#1643MEANS AND METHODS FOR DIAGNOSING AND TREATING AFFECTIVE DISORDERS
#1644Deletion mutants of tetrodotoxin-resistant sodium channel alpha subunit
#1645Methods for the Treatment of Autoimmune Diseases
#1646Compositions and methods for regulation of calcium-dependent signaling in brain
#1647Methods of diagnosis of spinal muscular atrophy and treatments thereof
#1648Compositions and methods for increasing bone mineralization
#1649Identification of an evolutionarily conserved pathway mediating transrepression of inflammatory response genes by nuclear receptors
#1650High-throughput screen for identifying selective persistent sodium channels channel blockers
#1651High-throughput screen for identifying selective persistent sodium channels channel blockers
#1652Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1653MONITOR PROTEINS USABLE FOR ANALYZING EXPRESSION OF MEMBRANE PROTEINS
#1654Treatment of insulin resistance
#1655METHODS OF TREATING NEUROLOGICAL CONDITIONS WITH HEMATOPOEITIC GROWTH FACTORS
#1656TANGO 240 nucleic acids and uses thereof
#1657Methods of treating neurological conditions with hematopoeitic growth factors
#1658Artificial binding proteins based on ubiquitin
#1659Cystic fibrosis transmembrane conductance regulator gene mutations
#1660METHODS OF TREATING NEUROLOGICAL CONDITIONS WITH HEMATOPOEITIC GROWTH FACTORS
#1661MARKs as Modifiers of the p53 Pathway and Methods of Use
#1662Methods for diagnosing an attention-deficit/Hyperactivity disorder
#1663Methods For Detecting Calcium Ion Influx
#1664Salt Taste Receptor and its Use in an Assay for Salt Taste
#1665Cystic fibrosis transmembrane conductance regulator gene mutations
#1666Means and Methods For Treating a Disease Which is Associated With an Excess Transport of Hyaluronan Across a Lipid Bilayer
#1667Method for screening for compounds using MHC class II invariant chain polypeptide and macrophage migration inhibitory factor
#1668Methods for modulating the sensation of satiety perception and agents useful for same
#1669Use of Haptoglobin and Hemoglobin to Modulate Na Ion Transport in a Vertebrate
#1670Method for identifying a ligand capable of selectively modulating a functional cascade involving a target, and uses thereof for high-throughput screening of molecules of interest
#1671Method for Determining Responsiveness to Chk1 Inhibitors
#1672Methods for treating neural cell swelling
#1673Compositions and Methods for Assaying hERG Channel Binding
#1674Ion flux in biological processes, and methods related thereto
#1675Ion-selective quantum dots
#1676Methods of Using FOXP3 Levels to Predict the Outcome of Organs Undergoing Acute Rejection
#1677Antibodies to non-functional P2Xreceptor
#1678SpiceMatrix Technology for Taste Compound Identification
#1679Methods of diagnosing cervical cancer
#1680Method for Detecting Conformational Change of Calmodulin, a Method for Screening a Substance Having an Activity that Affects to Conformational Change of Calmodulin
#1681Early Detection of Sepsis
#1682Compositions and Methods for the Treatment of Cystic Fibrosis and other Pulmonary Disorders
#1683TRPM2-specfic inhibitors
#1684IGFBP2 BIOMARKER
#1685Human salty taste receptor and methods of modulating salty taste perception
#1686Fluorescent substrates for neurotransmitter transporters
#1687Pesticidal compositions and methods of use
#1688Method of Screening Antiobesity Agents
#1689SCDs As Modifiers of the p53 Pathway and Methods of Use
#1690High temperature ion channels and pores
#1691Channel Current Cheminformatics and Bioengineering Methods for Immunological Screening, Single-Molecule Analysis, and Single-Molecular-Interaction Analysis
#1692Simultaneous assay of target and target-drug binding
#1693CRAC modulators and use of same for drug discovery
#1694CDK9 as modifier of the IGF pathway and methods of use
#1695Use of T-cell immune response cDNA 7 (TIRC7) in angiogenic and anti-angiogenic therapy
#1696Method for determining the immune status of a subject
#1697Materials and Methods for Modulating Cell Motility
#1698METHOD FOR USING DIVISION ARRESTED CELLS IN SCREENING ASSAYS
#1699Transient receptor potential channel TRPM8 and its use
#1700Modulators of ATP-binding cassette transporters
#1701FUNCTION HOMOLOGY SCREENING
#1702Novel Sodium Channel
#1703Calcium-sensing receptor 2 (CAR2) and methods for using
#1704FUNCTION HOMOLOGY SCREENING
#1705DOMINANT NEGATIVE LIGAND DRUG DISCOVERY SYSTEM
#1706TEL/Etv6-mediated inhibition of cell proliferation
#1707Compositions and methods relating to polycystic kidney disease
#1708Means and methods for diagnosing and treating affective disorders
#1709Methods for the treatment of cellular proliferative disorders
#1710Biological Marker for Inflammation
#1711Compositions and methods for transient receptor potential vanilloid (TRPV) channel mediated treatments
#1712Methods for determining cellular response to stimuli
#1713Screening assay for inhibitors of TRPA1 activation by a lower alkyl phenol
#1714Methods for tissue analysis
#1715L-glutamate-gated chloride channel proteins from
#1716CRAC channel and modulator screening methods
#1717Methods of screening for TRPM4 modulators of insulin secretion
#1718Quadruple Transformed Cell Line Useful for the Identification of Transport Inhibitors
#1719TRPC6 involved in glomerulonephritis
#1720Membrane devices with elastic energy barriers
#1721Novel TWIK-6, TWIK-7, IC23927, TWIK-8, IC47611, IC47615, HNMDA-1, TWIK-9, alpha2delta-4, 8099, 46455, 54414, 53763, 97076, 97102, 44181, 67084Fl and 67084alt molecules and uses therefor
#1722NOGO RECEPTOR FUNCTIONAL MOTIFS, PEPTIDE MIMETICS, AND MUTATED FUNCTIONAL MOTIFS RELATED THERETO, AND METHODS OF USING THE SAME
#1723IRF-5 HAPLOTYPES IN SYSTEMIC LUPUS ERYTHEMATOSUS
#1724Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease
#1725CFTR polypeptides methods to overcome biosynthetic misprocessing
#1726Modulation of Programmed Necrosis
#1727Method for the Detection of Intracellular Parameters With Luminescent Protein Probes for the Screening of Molecules Capable of Altering Said Parameters
#1728Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a chloride intracellular channel 1 protein
#1729T1R taste receptors and genes encoding same
#1730Bacterial iron acquisition targets
#1731Methods and Compositions for Modulating Satiety
#1732Nuclear transfer promoter for Rac protein and method of screening the same
#1733Method for Examining the Activity of Ion Channels
#1734Methods Of Treating Demyelinating Disorders
#1735Histone modifications as binary switches controlling gene expression
#1736Uses of 1-amino-3-(N,N-dimethylamino)-propylidene-1,1-bisphosphonic acid
#1737Organic cation transporter preferentially expressed in hematopoietic cells and leukemias and uses thereof
#1738Methods of Therapy and Diagnosis Using Targeting of Cells that Express Killer Cell Immunoglobulin like Receptor like Proteins
#1739Light-activated cation channel and uses thereof
#1740High throughput assay systems and methods for identifying agents that alter surface expression of integral membrane proteins
#1741Photoproteins with enhanced bioluminescence and assays using the same
#1742Novel Spiroindoline or Spiroisoquinoline Compounds, Methods of Use and Compositions Thereof
#1743Modulators of ATP-binding cassette transporters
#1744Organic anion transport proteins
#1745Neuroprotection with Beta-Lactam Compounds
#1746Human FGF-21 gene and gene expression products
#1747Methods of treating age-related macular degeneration by compstatin and analogs thereof
#1748Amyloid beta protein channel structure and uses thereof in identifying potential drug molecules for neurodegenerative diseases
#1749Methods of identifying an agent capable of interfering with Rad9 dephosphorylation
#1750Process for identifying substances which modulate the activity of hyperpolarization-activated cation channels
#1751Transporter-targeted methods of diagnosis and treatment
#1752Lipoparticles comprising ion channels, methods of making and using the same
#1753Methods for Modulating an Immune Response by Modulating Krc Activity
#1754SVCT2 transporters expressed in blood brain barrier cells
#1755Neuregulin variants and methods of screening and using thereof
#1756Methods for identifying modulators of hedgehog autoprocessing
#1757Use Of T-Cadherin As A Target
#1758Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same
#1759Integrase-dirived HIV-inhibiting agents
#1760ELISA for VEGF
#1761Test system for measuring the interaction of STAT 6 with NCoA-1
#1762Novel compositions and methods for modulation of the acid-sensing ion channel (ASIC) for the treatment of anxiety and drug addiction
#1763Modulators of ion channel trpa1
#1764Methods of determining activity of ryanodine receptor modulators
#1765Diagnostics and therapeutics for diseases associated with kallikrein 13 (klk13)
#1766Mechanosensitive ion channels and methods of use
#1767Methods of inhibiting cancer growth by binding to nuclear receptors
#1768Gm1 promoter and use thereof
#1769Nucleic acid molecules encoding novel murine low-voltage activated calcium channel proteins, designated-alpha1h, encoded proteins and methods of use thereof
#1770METHOD FOR DETECTING MODULATORS OF ION CHANNELS USING THALLIUM (I) SENSITIVE ASSAYS
#1771Ion channel
#1772Radiolabeled astemizole and method of making
#1773Use of vanilloid 4 receptor and antagonists or agonists thereof for treating diseases associated with pain
#1774Isolated nucleic acids for mutant mammalian Nav 1 proteins
#1775Screening of compounds for OCTN2 transporter activity
#1776Screening of compounds for BGT1 transporter activity
#1777Novel translocation assay
#1778Stable cell lines expressing hERG
#1779Modulation of synaptic maintenance
#1780METHODS AND COMPOSITIONS FOR MODULATING HGF/MET
#1781Systems of diagnosing cervical cancer
#1782NP95: methods of assaying for cell cycle modulators
#1783Serum-free expansion of cells in culture
#1784Human FGF-21 gene and gene expression products
#1785(+)-TRANS-4-(1-AMINOETHYL)-1-(4-PYRIDYCARBAMOYL)-CYCLOHEXANE AND METHOD FOR PROMOTING NEURAL GROWTH IN THE CENTRAL NERVOUS SYSTEM AND IN A PATIENT AT A SITE OF NEURONAL LESION
#1786Anti-α2 integrin antibodies and their uses
#1787Rhesus monkey P2X7 purinergic receptor and uses thereof
#1788Scintillation proximity assay for the identification of P-glycoprotein modulators
#1789Rat calcium channel subunits and related probes, cell lines and methods
#1790High throughput screening assay for the TRPM5 ion channel
#1791NF-κB activating gene
#1792Recombined cell system for deorphanizing g protein-coupled receptors
#1793Polypeptide complex of TRPM8 and calmodulin and its uses thereof
#1794Compositions and methods for identifying modulators of TRPV2
#1795Crystal of a transporter-ligand complex and methods of use
#1796High-affinity choline transporter
#1797Ion channel
#1798Methods and compositions for treating cervical cancer
#1799Modulation of mesenchymal and metastatic cell growth
#1800High-throughput screening assay for Na, K-ATPase using atomic absorption spectroscopy